Healthcare provider profile · identity verified

Augustine A Dolcich, MD

Family Practice · CHANTILLY, VA · NPI 1346234648

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	353	109
Levothyroxine Sodium	Levothyroxine Sodium	259	70
Losartan Potassium	Losartan Potassium	235	70
Zolpidem Tartrate	Zolpidem Tartrate	171	37
Alprazolam	Alprazolam	152	48
Tamsulosin Hcl	Tamsulosin Hcl	150	54
Amlodipine Besylate	Amlodipine Besylate	140	46
Lisinopril	Lisinopril	135	42
Metoprolol Succinate	Metoprolol Succinate	132	43
Pantoprazole Sodium	Pantoprazole Sodium	129	36
Azithromycin	Azithromycin	116	77
Rosuvastatin Calcium	Rosuvastatin Calcium	108	34
Simvastatin	Simvastatin	108	28
Escitalopram Oxalate	Escitalopram Oxalate	99	28
Metformin Hcl	Metformin Hcl	92	26
Hydrochlorothiazide	Hydrochlorothiazide	84	26
Ozempic	Semaglutide	66	suppressed
Gabapentin	Gabapentin	62	15
Albuterol Sulfate Hfa	Albuterol Sulfate	59	33
Metformin Hcl Er	Metformin Hcl	55	16
Finasteride	Finasteride	54	21
Trazodone Hcl	Trazodone Hcl	53	21
Furosemide	Furosemide	50	16
Meloxicam	Meloxicam	50	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	20
Montelukast Sodium	Montelukast Sodium	49	14
Omeprazole	Omeprazole	49	15
Duloxetine Hcl	Duloxetine Hcl	48	16
Carvedilol	Carvedilol	47	15
Eliquis	Apixaban	43	13
Pravastatin Sodium	Pravastatin Sodium	43	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	41	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Clonazepam	Clonazepam	39	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	20
Cefdinir	Cefdinir	38	27
Diclofenac Sodium Er	Diclofenac Sodium	37	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	19
Ibandronate Sodium	Ibandronate Sodium	36	12
Sertraline Hcl	Sertraline Hcl	35	14
Bupropion Xl	Bupropion Hcl	34	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	14
Methylprednisolone	Methylprednisolone	30	22
Ondansetron Odt	Ondansetron	30	17
Prednisone	Prednisone	30	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	16
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	11
Glimepiride	Glimepiride	27	11
Tramadol Hcl	Tramadol Hcl	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Levofloxacin	Levofloxacin	25	18
Telmisartan	Telmisartan	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Testosterone	Testosterone	23	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Atenolol	Atenolol	19	suppressed
Diazepam	Diazepam	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Famotidine	Famotidine	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Topiramate	Topiramate	13	suppressed
Cephalexin	Cephalexin	12	11
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystatin	Nystatin	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Colchicine	Colchicine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Terconazole	Terconazole	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error